Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Traumatic Brain Injury (TBI)
CE credit is not available for previously recorded sessions.
Medical Expertise is Just a Call Away with Genex’s ClinicalCare24
WAYNE, PA —When a workplace injury or illness occurs, employees often don’t know where to go, who to call or even if treatment is
Is the Supply Chain Creating Critical Drug Shortages?
With the country well into the holiday season, issues with supply chains have made their way into pharmacies across the nation. Recently, the Food and Drug Administration (FDA) showed that there are about 111 drugs on backorder. These include medications for heart conditions, antibiotics, and cancer drugs. Currently, there are no medications on the list that represent a large volume of active prescriptions for workers’ compensation.
The changing workforce drew much of our attention in 2021
We want to wish you a safe and happy holiday season. Below is a compendium of some of our most popular blogs from 2021—topics that ranged from the state of the nation’s labor force to the pandemic.
Reflections, Predictions and Gratitude from Enlyte Experts as 2021 Comes to a Close
From navigating year two of the pandemic to accepting our “new normal,” our experts are thankful for the teams and relationships we have strengthened while expressing hope and eagerness for the possibilities the new year will bring.
Washington State Formulary Update
Washington state has announced updates to its drug formulary, effective January 1, 2022. The following is a list of updated drugs and therapeutic classes (or class codes) and their status on the Washington State Department of Labor and Industries outpatient formulary.